NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July…
SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- B612 Foundation today announced the recipient of the annual Schweickart Prize, a program that…
Judges say Kavalan's Solist Fino Sherry 'stunned' panel with balance and complexity TAIPEI, July 1, 2025 /PRNewswire/ -- Kavalan has…
WASHINGTON, June 17, 2025 /PRNewswire/ -- The Taxpayers Protection Alliance (TPA) is leading a robust and candid panel discussion on…
QIAGEN to create a multimodal panel using next-generation sequencing (NGS) technology for detecting clinically relevant gene alterations in hematological malignancies…
- The Company is developing an enhanced immunosuppressive regimen in consultation with a panel of multi-disciplinary clinical experts and engaging…